Mumbai-headquartered Bharat Serums and Vaccines Limited (BSV) hosted the groundbreaking ceremony of its new manufacturing plant at Genome Valley in Hyderabad, Telengana. The company is owned by Advent, an American private equity fund. Spread across 10 acres, the $22 million manufacturing facility will increase the company's capacity to produce injectables...